NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Vascular repair plays important roles in postischemic remodeling and rehabilitation in cardiovascular and cerebrovascular disease, such as stroke and myocardial infarction. Nicotinamide adenine dinucleotide (NAD), a well-known coenzyme involved in electron transport chain for generation of adenosine triphosphate, has emerged as an important controller regulating various biological signaling pathways. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme for NAD biosynthesis in mammals. NAMPT may also act in a nonenzymatic manner, presumably mediated by unknown receptor(s). Rapidly accumulating data in the past decade show that NAMPT and NAMPT-controlled NAD metabolism regulate fundamental biological functions in endothelial cells, vascular smooth muscle cells, and endothelial progenitor cells. The NAD-consuming proteins, including sirtuins, poly-ADP-ribose polymerases (PARPs), and CD38, may contribute to the regulatory effects of NAMPT-NAD axis in these cells and vascular repair. This review discusses the current data regarding NAMPT and NAMPT-controlled NAD metabolism in vascular repair and the clinical potential translational application of NAMPT-related products in treatment of cardiovascular and cerebrovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedCantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · cited 1×
“NAD is a well-known coenzyme that plays a foremost role in electron transport chain to generate adenosine triphosphate through oxidative phosphorylation.(9,10) As electron Received for publication August 25, 2015; accepted September 30, 2015.”
BackgroundNAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481 · cited 1×
“Sirtuins regulate posttranslational modifications by removing chemical groups such as acetyl, malonyl, myristoyl, and palmitoyl from proteins.(14) PARPs are a family of enzymes that use the ADP-ribose groups in NAD to form branched ADP-ribose polymers to repair DNA strand breaks or kinks.”
BackgroundCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Gibson, B. A., & Kraus, W. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3376 · Cited by 1,226 · cited 1×
“PARPs are a family of enzymes that use the ADP-ribose groups in NAD to form branched ADP-ribose polymers to repair DNA strand breaks or kinks.(15) CD38 is a surface receptor and an enzyme metabolizing NAD to generate Ca2+-mobilizing messengers, including cyclic ADP ribose and ADP ribose.”
BackgroundNutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.035 · Cited by 950 · cited 1×
“metabolism control,(28) circadian clock,(29,30) immunity/inflammation,(31,32) lifespan,(33) and cell death.(34) NAMPT exists in intracellular and extracellular forms.”
BackgroundNampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911 · cited 1×
“The extracellular NAMPT was supposed to be a ligand of the insulin receptor; however, this effect was not reproduced.(28) So the nonenzymatic action mode of extracellular NAMPT still remains to be exactly elucidated because numerous studies have reported that extracellular NAMPT is able to regulate cell events such as…”
BackgroundThe secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899 · cited 1×
“However, a number of recent studies have provided compelling evidence of the novel role of NAD, with the most notable being an important signaling regulator.(11,12) NAD can act as a substrate for a group of enzymes, which are called NAD-consuming proteins, including sirtuins, poly-ADP-ribose polymerases (PARPs), and C…”
BackgroundBieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
SIRT1 Controls Endothelial Angiogenic Functions During Vascular Growth
Potente, M., Ghaeni, L., Baldessari, D., Mostoslavsky, R., Rossig, L., Dequiedt, F., Haendeler, J., Mione, M., Dejana, E., Alt, F. W., et al. (2007) · Genes & Development · doi:10.1101/gad.435107 · Cited by 608
Cited by
Metrnl: A secreted protein with new emerging functions
Zheng, S.-L., Li, Z.-Y., Song, J., Liu, J.-M., & Miao, C.-Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.9 · Cited by 190
Self-citationChen, J., Sysol, J. R., Singla, S., Zhao, S., Yamamura, A., Valdez-Jasso, D., Abbasi, T., Shioura, K. M., Sahni, S., Reddy, V., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024557 · Cited by 86
Mateuszuk, Ł., Campagna, R., Kutryb-Zając, B., Kuś, K., Słominska, E. M., Smolenski, R. T., & Chlopicki, S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114019 · Cited by 81
Watson, A., Nong, Z., Yin, H., O’Neil, C., Fox, S., Balint, B., Guo, L., Leo, O., Chu, M. W. A., Gros, R., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.310022 · Cited by 72
Metadata
- Authors
- Wang, P., Li, W.-L., Liu, J.-M., & Miao, C.-Y.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 2016-06
- Volume
- 67
- Issue
- 6
- Pages
- 474-481
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W1796529988
- Cited by
- 32
- References
- 18
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair. https://app.cochat.ai/papers/10.1097/fjc.0000000000000332
- The paper
- Wang, P., Li, W.-L., Liu, J.-M., & Miao, C.-Y. (2016). NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0000000000000332
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.